GUBBA PHARMA IN E NEWS

Sun Pharma honours IIT Kanpur’s professor with Science Foundation Research Award-2021

January 25, 2022 Gubba Pharma In E News

Sun Pharma has honoured one of the professors, Dr Bushra Ateeq, Biological Sciences and Bioengineering (BSBE) Department, IIT Kanpur, with Science Foundation Research Award-2021 in...

Continue Reading

Cadila Healthcare receives final approval for seizures treatment drug

January 25, 2022 Gubba Pharma In E News

Cadila Healthcare announced that it has received final approval from the USFDA to market vigabatrin tablets in the strength of 500 mg. Vigabatrin is used...

Continue Reading

Dr. Chandak of CCMB selected for Sun Pharma Science Foundation Research award

January 19, 2022 Gubba Pharma In E News

Senior scientist from Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) Dr G R Chandak has been selected for Sun Pharma Science Foundation Research Award-2021...

Continue Reading

‘We are hoping Corbevax could be vax for the world’

January 19, 2022 Gubba Pharma In E News

Corbevax, the covid vaccine of the Baylor College of Medicine, Houston, and Hyderabad-based Biological E Ltd, is drawing attention for being a model for the...

Continue Reading

Indian firm launches Merck’s Covid pill under brand name ‘molulife’

January 19, 2022 Gubba Pharma In E News

Drug major Mankind Pharma and generics maker BDR pharmaceuticals has announced launch of Merck’s oral Covid-19 anti-viral pill Molnupiravir under the brand name Molulife. Over...

Continue Reading

Pfizer Plans To Introduce Hybrid Vaccine Targeting Omicron Variant By March: Reports

January 12, 2022 Gubba Pharma In E News

In a new development on the vaccine front, Pfizer Inc is developing a hybrid vaccine that will comprise of the original shot with a formulation...

Continue Reading

Granules India gets USFDA nod for its generic Amphetamine mixed salts

January 12, 2022 Gubba Pharma In E News

Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment...

Continue Reading

Mankind Pharma to Launch Cheapest Covid Antiviral Drug Molnupiravir at Rs 35 Per Capsule by Next Week: Report

January 5, 2022 Gubba Pharma In E News

Mankind Pharma’s chairman has said the company’s will launch the cheapest Molnupiravir, the Covid-19 antiviral drug, at Rs 35 per capsule, the Economic Times said...

Continue Reading

Glenmark expects antiviral nasal spray from SaNOtize to be available early 2022

January 5, 2022 Gubba Pharma In E News

As the world remains anxious for innovative tools to tackle the coronavirus, drugmaker Glenmark Pharmaceuticals expects the antiviral nasal spray from SaNOtize to be available...

Continue Reading